Gang Feng Qing Li Haibo Zhu Yanyu Jiang Jijun Yuan Yingxin Fu Qi Deng
10.3389/fonc.2021.726134
Front Oncol
2021 Sep 16;11:726134.
t cells chimeric antigen receptor diffuse large b-cell lymphoma post-transplant lymphoproliferative disease programmed cell death 1
CC BY
https://pubmed.ncbi.nlm.nih.gov/34604065/
Case Reports
PMC8481808
34604065
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review
2021